Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.

about

The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.Aromatase inhibitors: from bench to bedside and back.

P2860

Q24683853-5FF293AB-1106-40C8-991E-5910C1955287 Q43236564-50813D68-8CC1-4993-AD2E-E7B994A9E3CB Q46788411-16497382-F4A4-45F7-83BC-16C4845AD04C

P2860

Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.

Item

http://www.wikidata.org/entity/Q35993244

description

1991 nî lūn-bûn

@nan

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

1991年论文

@zh

1991年论文

@zh-cn

name

Endocrine, pharmacokinetic and ...... pausal breast cancer patients.

@ast

Endocrine, pharmacokinetic and ...... pausal breast cancer patients.

@en

type

Item

label

Endocrine, pharmacokinetic and ...... pausal breast cancer patients.

@ast

Endocrine, pharmacokinetic and ...... pausal breast cancer patients.

@en

prefLabel

Endocrine, pharmacokinetic and ...... pausal breast cancer patients.

@ast

Endocrine, pharmacokinetic and ...... pausal breast cancer patients.

@en

P1476

Endocrine, pharmacokinetic and ...... pausal breast cancer patients.

@en

P2093

Coombes RC

http://www.w3.org/2001/XMLSchema#string

Dowsett M

http://www.w3.org/2001/XMLSchema#string

Haynes B

http://www.w3.org/2001/XMLSchema#string

Jarman M

http://www.w3.org/2001/XMLSchema#string

Jones A

http://www.w3.org/2001/XMLSchema#string

MacNeill F

http://www.w3.org/2001/XMLSchema#string

Mehta A

http://www.w3.org/2001/XMLSchema#string

Newton C

http://www.w3.org/2001/XMLSchema#string

Powles TJ

http://www.w3.org/2001/XMLSchema#string

P2860

Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer

Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer

Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide.

Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma.

Compensatory increase in TSH secretion without effect on prolactin secretion in patients treated with aminoglutethimide.

Analogues of aminoglutethimide: selective inhibition of aromatase.

Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patients.

Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer.

Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer.

Metabolic clearance rate (MCR) of dehydroepiandrosterone sulfate (DS), its metabolism to dehydroepiandrosterone, androstenedione, testosterone, and dihydrotestosterone, and the effect of increased plasma DS concentration on DS MCR in normal women.

P2888

bjc.1991.420

P304

887-894

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1991.420

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Per Eystein Lønning

P577

1991-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21223601

http://www.w3.org/2001/XMLSchema#string

P6179

1002839180

http://www.w3.org/2001/XMLSchema#string

P698

1931611

http://www.w3.org/2001/XMLSchema#string

P932

1977449

http://www.w3.org/2001/XMLSchema#string

Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.

about

P2860

P2860

Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P932